Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 3
Study Completion Date
October 2018
October 2018
NCT02048813Uploaded 03-31-2023
Access via NCI by Request
PDS UID: nci-data-513
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Files: NCT02048813-D1



Data DictionaryNCT02048813-D1-Data-Dictionary_2.pdf

DATANCT02048813-D1-Dataset_3.txt

OTHERREADME.pdf
Files: NCT02048813-D2



Data DictionaryNCT02048813-D2-Data-Dictionary_2.pdf

DATANCT02048813-D2-Dataset_2.txt

OTHERREADME.pdf
Files: NCT02048813-D3



Data DictionaryNCT02048813-D3-Data-Dictionary_2.pdf

DATANCT02048813-D3-Dataset_2.txt

OTHERREADME.pdf